Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Detect EGFR T790M Mutation in ctDNA of Chinese Advanced/Metastatic NSCLC Patients by Cobas, Super-ARMS, Digital PCR and NGS and Evaluate Clinical Outcomes of T790M Mutation Positive Patients Who Had AZD9291 Monotherapy

NCT02997501 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT02997501
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02997501 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Detect EGFR T790M Mutation in ctDNA of Chinese Advanced/Metastatic NSCLC Patients by Cobas, Super-ARMS, Digital PCR and NGS and Evaluate Clinical Outcomes of T790M Mutation Positive Patients Who Had AZD9291 Monotherapy
Lead sponsor
AstraZeneca
Phase
Phase 3
Overall status
Completed
Start date
December 23, 2016
Completion date
October 24, 2018
Enrollment
256 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer